Literature DB >> 15385491

A new cruzipain-mediated pathway of human cell invasion by Trypanosoma cruzi requires trypomastigote membranes.

Isabela M Aparicio1, Julio Scharfstein, Ana Paula C A Lima.   

Abstract

The intracellular protozoan Trypanosoma cruzi causes Chagas' disease, a chronic illness associated with cardiomyopathy and digestive disorders. This pathogen invades mammalian cells by signaling them through multiple transduction pathways. We previously showed that cruzipain, the main cysteine protease of T. cruzi, promotes host cell invasion by activating kinin receptors. Here, we report a cruzipain-mediated invasion route that is not blocked by kinin receptor antagonists. By testing different strains of T. cruzi, we observed a correlation between the level of cruzipain secreted by trypomastigotes and the capacity of the pathogen to invade host cells. Consistent with a role for cruzipain, the cysteine protease inhibitor N-methylpiperazine-urea-Phe-homophenylalanine-vinylsulfone-benzene impaired the invasion of human smooth muscle cells by strains Dm28c and X10/6 but not by the G isolate. Cruzipain-rich supernatants of Dm28c trypomastigotes enhanced the infectivity of isolate G parasites twofold, an effect which was abolished by the cysteine protease inhibitor l-trans-epoxysuccinyl-leucylamido-(4-guanidino)butane and by thapsigargin, a drug that induces depletion of the intracellular Ca(2+) stores. The enhancement due to Dm28 supernatants was abolished upon cruzipain immunodepletion, and the activity was restored by purified cruzipain. In contrast, supernatants from isolate G trypomastigotes (with low levels of cruzipain) or supernatants from Dm28c epimastigotes or purified cruzipain alone did not enhance parasite invasion, indicating that the protease is required but not sufficient to engage this invasion pathway. We provide evidence that activation of this pathway requires cruzipain-mediated processing of a trypomastigote molecule associated with parasite-shed membranes. Our results couple cruzipain to host cell invasion through a kinin-independent route and further suggest that high-level cruzipain expression may contribute to parasite infectivity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15385491      PMCID: PMC517595          DOI: 10.1128/IAI.72.10.5892-5902.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Cysteine protease isoforms from Trypanosoma cruzi, cruzipain 2 and cruzain, present different substrate preference and susceptibility to inhibitors.

Authors:  A P Lima; F C dos Reis; C Serveau; G Lalmanach; L Juliano; R Ménard; T Vernet; D Y Thomas; A C Storer; J Scharfstein
Journal:  Mol Biochem Parasitol       Date:  2001-04-25       Impact factor: 1.759

2.  Heparan sulfate modulates kinin release by Trypanosoma cruzi through the activity of cruzipain.

Authors:  Ana Paula C A Lima; Paulo C Almeida; Ivarne L S Tersariol; Veronica Schmitz; Alvin H Schmaier; Luiz Juliano; Isaura Y Hirata; Werner Müller-Esterl; Jair R Chagas; Julio Scharfstein
Journal:  J Biol Chem       Date:  2001-11-28       Impact factor: 5.157

3.  Trypanosoma cruzi prolyl oligopeptidase Tc80 is involved in nonphagocytic mammalian cell invasion by trypomastigotes.

Authors:  P Grellier; S Vendeville; R Joyeau; I M Bastos; H Drobecq; F Frappier; A R Teixeira; J Schrével; E Davioud-Charvet; C Sergheraert; J M Santana
Journal:  J Biol Chem       Date:  2001-10-11       Impact factor: 5.157

4.  Surface antigens of metacyclic trypomastigotes of Trypanosoma cruzi.

Authors:  N Yoshida
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

Review 5.  Cell signalling and Trypanosoma cruzi invasion.

Authors:  Barbara A Burleigh; Aaron M Woolsey
Journal:  Cell Microbiol       Date:  2002-11       Impact factor: 3.715

6.  Trypanosoma cruzi induces edematogenic responses in mice and invades cardiomyocytes and endothelial cells in vitro by activating distinct kinin receptor (B1/B2) subtypes.

Authors:  Alex G Todorov; Daniele Andrade; João B Pesquero; Ronaldo de Carvalho Araujo; Michael Bader; John Stewart; Lajos Gera; Werner Müller-Esterl; Verônica Morandi; Regina C S Goldenberg; Hugo Castro-Faria Neto; Julio Scharfstein
Journal:  FASEB J       Date:  2002-11-01       Impact factor: 5.191

7.  Oligopeptidase B-dependent signaling mediates host cell invasion by Trypanosoma cruzi.

Authors:  E V Caler; S Vaena de Avalos; P A Haynes; N W Andrews; B A Burleigh
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

8.  Subsite specificity (S3, S2, S1', S2' and S3') of oligopeptidase B from Trypanosoma cruzi and Trypanosoma brucei using fluorescent quenched peptides: comparative study and identification of specific carboxypeptidase activity.

Authors:  Jefferson P Hemerly; Vitor Oliveira; Elaine Del Nery; Rory E Morty; Norma W Andrews; Maria A Juliano; Luiz Juliano
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

9.  Identification, characterization and localization of chagasin, a tight-binding cysteine protease inhibitor in Trypanosoma cruzi.

Authors:  A C Monteiro; M Abrahamson; A P Lima; M A Vannier-Santos; J Scharfstein
Journal:  J Cell Sci       Date:  2001-11       Impact factor: 5.285

10.  Host cell invasion by Trypanosoma cruzi is potentiated by activation of bradykinin B(2) receptors.

Authors:  J Scharfstein; V Schmitz; V Morandi; M M Capella; A P Lima; A Morrot; L Juliano; W Müller-Esterl
Journal:  J Exp Med       Date:  2000-11-06       Impact factor: 14.307

View more
  26 in total

1.  Blood-brain barrier traversal by African trypanosomes requires calcium signaling induced by parasite cysteine protease.

Authors:  Olga V Nikolskaia; Ana Paula C de A Lima; Yuri V Kim; John D Lonsdale-Eccles; Toshihide Fukuma; Julio Scharfstein; Dennis J Grab
Journal:  J Clin Invest       Date:  2006-09-21       Impact factor: 14.808

2.  Induction of autophagy increases the proteolytic activity of reservosomes during Trypanosoma cruzi metacyclogenesis.

Authors:  Antonella Denise Losinno; Santiago José Martínez; Carlos Alberto Labriola; Carolina Carrillo; Patricia Silvia Romano
Journal:  Autophagy       Date:  2020-02-04       Impact factor: 16.016

3.  Synthesis and evaluation of the antileishmanial activity of silver compounds containing imidazolidine-2-thione.

Authors:  Patrícia Ferreira Espuri; Larissa Luiza Dos Reis; Eduardo de Figueiredo Peloso; Vanessa Silva Gontijo; Fábio Antônio Colombo; Juliana Barbosa Nunes; Carine Ervolino de Oliveira; Eduardo T De Almeida; Débora E S Silva; Jessica Bortoletto; Daniel Fonseca Segura; Adelino V G Netto; Marcos José Marques
Journal:  J Biol Inorg Chem       Date:  2019-04-04       Impact factor: 3.358

4.  Trypanosoma cruzi-secreted vesicles have acid and alkaline phosphatase activities capable of increasing parasite adhesion and infection.

Authors:  Roberta F C Neves; Anne C S Fernandes; José R Meyer-Fernandes; Thais Souto-Padrón
Journal:  Parasitol Res       Date:  2014-06-07       Impact factor: 2.289

5.  Reversible cysteine protease inhibitors show promise for a Chagas disease cure.

Authors:  Momar Ndao; Christian Beaulieu; W Cameron Black; Elise Isabel; Fabio Vasquez-Camargo; Milli Nath-Chowdhury; Frédéric Massé; Christophe Mellon; Nathalie Methot; Deborah A Nicoll-Griffith
Journal:  Antimicrob Agents Chemother       Date:  2013-12-09       Impact factor: 5.191

6.  Molecular and biochemical characterization of a cathepsin B-like protease family unique to Trypanosoma congolense.

Authors:  Carlos Mendoza-Palomares; Nicolas Biteau; Christiane Giroud; Virginie Coustou; Theresa Coetzer; Edith Authié; Alain Boulangé; Théo Baltz
Journal:  Eukaryot Cell       Date:  2008-02-15

7.  In vitro and in vivo studies of the trypanocidal properties of WRR-483 against Trypanosoma cruzi.

Authors:  Yen Ting Chen; Linda S Brinen; Iain D Kerr; Elizabeth Hansell; Patricia S Doyle; James H McKerrow; William R Roush
Journal:  PLoS Negl Trop Dis       Date:  2010-09-14

8.  All Trypanosoma cruzi developmental forms present lysosome-related organelles.

Authors:  Celso Sant'Anna; Fabiola Parussini; Daniela Lourenço; Wanderley de Souza; Juan Jose Cazzulo; Narcisa Leal Cunha-e-Silva
Journal:  Histochem Cell Biol       Date:  2008-08-12       Impact factor: 4.304

9.  Investigation of 8-methoxy-3-(4-nitrobenzoyl)-6-propyl-2H-chromen-2-one as a promising coumarin compound for the development of a new and orally effective antileishmanial agent.

Authors:  Eduardo de Figueiredo Peloso; Rafaella Junqueira Merli; Patrícia Ferreira Espuri; Juliana Barbosa Nunes; Fábio Antônio Colombo; Elkin José Torres Sierra; Daniela Carvalho de Paulo; Marcelo Henrique Dos Santos; Diogo Teixeira Carvalho; Marcos José Marques
Journal:  Mol Biol Rep       Date:  2020-10-06       Impact factor: 2.316

10.  A cysteine protease inhibitor cures Chagas' disease in an immunodeficient-mouse model of infection.

Authors:  Patricia S Doyle; Yuan M Zhou; Juan C Engel; James H McKerrow
Journal:  Antimicrob Agents Chemother       Date:  2007-08-13       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.